Table 2.
Summary of key findings of studies on HBV vaccination of health workers from Sub-Saharan Africa from 2000 to 2015 (n = 33).
| Variable | Lowest value (%) | Highest value (%) | No. of studies |
|---|---|---|---|
| Awareness of HBV | 52.0 | 98.3 | 8 |
| Awareness of HBV vaccine | 70.2 | 98.0 | 5 |
| Vaccination status (“ever vaccinated”) | 0.0 | 91.9 | 29 |
| Vaccination status (complete vaccination) | 4.6 | 64.4 | 18 |
| Vaccination status (immune testing) | 0.0 | 12.7 | 8 |
| Lab-based markers overall | 60.1 | 76.6 | 2 |
| HBsAg | 4.0 | 25.7 | 6 |
| Anti-HBS | 22.2 | 61.6 | 3 |
| Anti-HBC | 41.0 | 92.0 | 5 |
| Reasons for non-vaccination (n = 10) | No. of studies citing reason |
|---|---|
| Cost | 8 |
| Unaware available | 7 |
| Inadequate information | 6 |
| Time | 3 |
| Vaccine not important | 3 |
| Ignorance | 2 |
| No reason | 2 |
| Potential side effects | 2 |
| No policy in place | 1 |
| Low-risk perception | 1 |
Anti-HBC, Hepatitis B core antibody; Anti-HBS, Hepatitis B surface antibody; HBV, Hepatitis B virus; HBsAg, Hepatitis B surface antigen.